Vnitr Lek 2008, 54(5):457-463

Urologic surgery in diabetes

M. Broďák*, M. Romžová, J. Košina
Urologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta doc. MUDr. Petr Morávek, CSc.

Introduction:
The diabetes mellitus is risk factor for urologic surgery. The best prevention of complications is excellent compensation of diabetes, appropriated management of anesthesia and good post surgery care. The diabetes is etiologic risk factor many urologic diseases including malignant.


Urologic surgery:
The diabetes is intensively evaluated in uro-oncology and it seems that renal cell carcinoma and bladder cancer incidence is higher in diabetic patients. The link between prostate cancer and diabetes is not clear, yet. The behavior of this cancer is more aggressive and it has worse prognosis. The diabetes is risk etiologic factor for urolithiasis and benign prostatic hyperplasia. Immunodeficiency combined with diabetes has negative impact for urinary tract infection including most serious as emphysematous pyelonephritis or Fournier gangrene external genitalia.

Conclusion:
The accurate compensation of the diabetes is basic condition good results of urologic surgery in diabetics. The diabetes mellitus and obesity will be evaluated as risk factors many diseases of kidneys and whole urologic apparatus especially malignant.

Keywords: diabetes mellitus; nephrectomy; prostatectomy; cystectomy; extracorporeal shock wave lithotripsy

Received: July 2, 2007; Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Broďák M, Romžová M, Košina J. Urologic surgery in diabetes. Vnitr Lek. 2008;54(5):457-463.
Download citation

References

  1. Calton BA et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 2007; 18: 493-503. Go to original source... Go to PubMed...
  2. Eknoyan G. Renal papillary necrosis. In: Massry SG, Glassorck RJ. Textbook of Nephrology. 4th ed. Baltimore (MD): Lippicott Williams & Wilkins 2001: 1004-1010.
  3. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-2225. Go to original source... Go to PubMed...
  4. Gong Z et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1977-1983. Go to original source... Go to PubMed...
  5. Chiu BC et al. Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes (Lond) 2006; 30: 940-947. Go to original source... Go to PubMed...
  6. Kane CJ et al. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol 2005; 173: 732-736. Go to original source... Go to PubMed...
  7. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-2062. Go to original source... Go to PubMed...
  8. Kravchick S. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol Oncol Res 2001; 7: 56-59. Go to original source... Go to PubMed...
  9. Larsson SC et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006; 49: 2819-2823. Go to original source... Go to PubMed...
  10. Lieske JC. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 2006; 48: 897-904. Go to original source... Go to PubMed...
  11. Ng Y, Husain I, Waterfall N. Diabetes mellitus and bladder cancer - an epidemiological relationship? Pathol Oncol Res 2003; 9: 30-31. Go to original source... Go to PubMed...
  12. Pan SY et al. Obesity, high energy intake, lack of physical activity, and the risk of kidney cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2453-2460. Go to original source... Go to PubMed...
  13. Platz FA et al. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res 2003; 63: 8542-8548.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.